Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Clinical parameters for determining hematologic toxicity prior to radioimmunotheraphy

Clinical parameters for determining hematologic toxicity prior to radioimmunotheraphy

US Patent 6451284 · Granted Sep 17, 2002

Estimated economic value: $81,257,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Treatment of diffuse large-cell lymphoma with anti-CD20 antibody2019
Treatment of diffuse large-cell lymphoma with anti-CD20 antibody2016
Treatment of diffuse large-cell lymphoma with anti-CD20 antibody2014
Treatment of aggressive non-Hodgkins lymphoma with anti-CD20 antibody2013
Treatment of chronic lymphocytic leukemia using anti-CD20 antibodies2012
Treatment of hematologic malignancies associated with circulating tumor cells us2010
Clinical parameters for determining hematologic toxicity prior to radioimmunothe2007
Clinical parameters for determining hematologic toxicity prior to radioimmunothe2007
Treatment of B-cell associated diseases2005
System for monitoring plant assets including machinery2002
Piezoelectric biosensor with a ladder polymer substrate coating1998
Monoclonal antibody specific for a mammary tumor cell surface antigen1991